Publicaciones (137) Publicaciones de JOSE MIGUEL CERDA NICOLAS

2022

  1. Desmoplastic infantile astrocytoma with atypical phenotype, PTEN homozygous deletion and BRAF V600E mutation

    Acta Neuropathologica Communications, Vol. 10, Núm. 1

  2. Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression

    Cancers, Vol. 14, Núm. 16

2021

  1. The status of egfr modulates the effect of mirna-200c on zeb1 expression and cell migration in glioblastoma cells

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-18

2020

  1. Identification of New Genetic Clusters in Glioblastoma Multiforme: EGFR Status and ADD3 Losses Influence Prognosis

    Cells, Vol. 9, Núm. 11

  2. Identification of a Novel BRCA1 Alteration in Recurrent Melanocytoma Resulting in Increased Proliferation

    Journal of neuropathology and experimental neurology, Vol. 79, Núm. 11, pp. 1233-1238

  3. Pam3CSK4, a TLR2 ligand, induces differentiation of glioblastoma stem cells and confers susceptibility to temozolomide

    Investigational New Drugs, Vol. 38, Núm. 2, pp. 299-310

  4. Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma

    Neoplasia (United States), Vol. 22, Núm. 1, pp. 10-21

2019

  1. Characterization of a new glioblastoma cell line, GB-val4, with unusual TP53 mutation

    Human Cell, Vol. 32, Núm. 4, pp. 557-567

  2. Epigenetic changes underlie the aggressiveness of histologically benign meningiomas that recur

    Human Pathology, Vol. 84, pp. 105-114

2018

  1. Allopurinol partially prevents disuse muscle atrophy in mice and humans

    Scientific Reports, Vol. 8, Núm. 1

  2. Study of the activation of TLR receptors in neurospheres from glioblastoma cells in vitro

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii12

2017

  1. Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma

    Cellular Oncology, Vol. 40, Núm. 4, pp. 389-399

  2. Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2

    Cytotechnology, Vol. 69, Núm. 4, pp. 539-550

  3. Molecular progression in unusual recurrent non-pediatric intracranial clear cell meningioma

    Current Oncology, Vol. 24, Núm. 3, pp. e244-e250

2016

  1. Chemopreventive effect of oleuropein in colitis-associated colorectal cancer in c57bl/6 mice

    Molecular Nutrition and Food Research, Vol. 60, Núm. 2, pp. 242-255

2015

  1. Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status

    Neuroscience, Vol. 297, pp. 243-251

  2. Evolution to malignancy: A genetic stepwise study of tumor suppressor genes loss in a recurrent meningioma

    Clinical Neuropathology

  3. Expression of the Chemokine Receptors CXCR3, CXCR4, CXCR7 and Their Ligands in Rhabdomyosarcoma

    Pathology and Oncology Research, Vol. 21, Núm. 4, pp. 1191-1199

2014

  1. BRAF V600E mutation in two distinct meningeal melanocytomas associated with a nevus of ota

    Journal of Clinical Oncology, Vol. 32, Núm. 20

  2. Correlation between EGFR amplification and the expression of MicroRNA-200c in primary glioblastoma multiforme

    PLoS ONE, Vol. 9, Núm. 7